Paper29985448
Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats.
Rodriguez R and 8 others. Hypertens Res, 2018. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats. Papers, record 29985448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29985448
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin II Type 1 Receptor Blockers | Major topic |
| Arterial Pressure | Major topic |
| Natriuresis | Major topic |
| Obesity | Major topic |
| Glucagon-Like Peptide-1 Receptor Agonists | Major topic |
| Animals | |
| Exenatide | |
| Heart Rate | |
| Rats | |
| Rats, Inbred OLETF | |
| Rats, Long-Evans |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 30111855 | An interesting cross-talk between the glucagon-like peptide-1 receptor axis and angiotensin receptor pathway for modulation of renal sodium handling in obesity. | https://conductscience.org/library/papers/30111855 |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17715265 | Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats. | Am J Physiol Renal Physiol | 2007 | https://conductscience.org/library/papers/17715265 | PubMed |
| 2 | 26803771 | GLP-1 Agonists and Blood Pressure: A Review of the Evidence. | Curr Hypertens Rep | 2016 | https://conductscience.org/library/papers/26803771 | PubMed |
| 3 | 24296712 | Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. | Diabetes | 2014 | https://conductscience.org/library/papers/24296712 | PubMed |
| 4 | 26447224 | The physiological role of glucagon-like peptide-1 in the regulation of renal function. | Am J Physiol Renal Physiol | 2016 | https://conductscience.org/library/papers/26447224 | PubMed |
| 5 | 10332947 | Influence of centrifugation and hindlimb suspension on testosterone and corticosterone excretion in rats. | Aviat Space Environ Med | 1999 | https://conductscience.org/library/papers/10332947 | PubMed |
| 6 | 12623970 | The kidney, hypertension, and obesity. | Hypertension | 2003 | https://conductscience.org/library/papers/12623970 | PubMed |
| 7 | 15485752 | Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. | Am J Hypertens | 2004 | https://conductscience.org/library/papers/15485752 | PubMed |
| 8 | 18786605 | The incretin system and its role in type 2 diabetes mellitus. | Mol Cell Endocrinol | 2009 | https://conductscience.org/library/papers/18786605 | PubMed |
| 9 | 26636423 | Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men. | Diabetes Obes Metab | 2016 | https://conductscience.org/library/papers/26636423 | PubMed |
| 10 | 21331058 | Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials. | Am J Hypertens | 2011 | https://conductscience.org/library/papers/21331058 | PubMed |
| 11 | 15691618 | Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives. | Am J Hypertens | 2005 | https://conductscience.org/library/papers/15691618 | PubMed |
| 12 | 19776173 | Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells. | Am J Physiol Renal Physiol | 2009 | https://conductscience.org/library/papers/19776173 | PubMed |
| 13 | 16980380 | Effect of ramipril on the incidence of diabetes. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16980380 | PubMed |
| 14 | 25677912 | GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. | Diabetes | 2015 | https://conductscience.org/library/papers/25677912 | PubMed |
| 15 | 8349321 | Obesity-induced hypertension. Renal function and systemic hemodynamics. | Hypertension | 1993 | https://conductscience.org/library/papers/8349321 | PubMed |
| 16 | 18981327 | Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study. | Hypertension | 2008 | https://conductscience.org/library/papers/18981327 | PubMed |
| 17 | 3588564 | Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. | Prev Med | 1987 | https://conductscience.org/library/papers/3588564 | PubMed |
| 18 | 17376762 | Aldosterone receptor antagonism exacerbates intrarenal angiotensin II augmentation in ANG II-dependent hypertension. | Am J Physiol Renal Physiol | 2007 | https://conductscience.org/library/papers/17376762 | PubMed |
| 19 | 25572181 | One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study. | Endocrine | 2015 | https://conductscience.org/library/papers/25572181 | PubMed |
| 20 | 17878513 | The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. | Pharmacol Rev | 2007 | https://conductscience.org/library/papers/17878513 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42709280 | Effects of heart failure pharmacotherapy on natriuresis and diuresis: A narrative review. | Heart Fail Rev | 2026 | https://conductscience.org/library/papers/42709280 | PubMed |
| 41102420 | Possible mechanisms of action of glucagon-like peptide-1 receptor agonists on blood pressure beyond body weight. | Hypertens Res | 2025 | https://conductscience.org/library/papers/41102420 | PubMed |
| 40891153 | Do obesity and visceral adiposity promote heart failure with reduced ejection fraction? | Eur Heart J | 2026 | https://conductscience.org/library/papers/40891153 | PubMed |
| 38477666 | Incretin and glucagon receptor polypharmacology in chronic kidney disease. | Am J Physiol Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38477666 | PubMed |
| 36398458 | Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats. | Clin Exp Pharmacol Physiol | 2023 | https://conductscience.org/library/papers/36398458 | PubMed |
| 32587574 | Partial Body Mass Recovery After Caloric Restriction Abolishes Improved Glucose Tolerance in Obese, Insulin Resistant Rats. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/32587574 | PubMed |
| 32384887 | GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation. | Cardiovasc Diabetol | 2020 | https://conductscience.org/library/papers/32384887 | PubMed |
| 30111855 | An interesting cross-talk between the glucagon-like peptide-1 receptor axis and angiotensin receptor pathway for modulation of renal sodium handling in obesity. | Hypertens Res | 2018 | https://conductscience.org/library/papers/30111855 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29985448
GET https://conductscience.org/api/papers/v1/29985448/references?page=2